OPK Opko Health Inc

USD 1.20 0.13 12.149533
Icon

Opko Health Inc (OPK) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.20

+0.13 (+12.15)%

USD 0.67B

0.03B

USD 3.00(+150.00%)

N/A

Icon

OPK

Opko Health Inc (USD)
COMMON STOCK | NSD
USD 1.20
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.67B

N/A

USD 1.20

Opko Health Inc (OPK) Stock Forecast

USD 3.00
(+150.00%)

Based on the Opko Health Inc stock forecast from 1 analysts, the average analyst target price for Opko Health Inc is USD 3.00 over the next 12 months. Opko Health Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Opko Health Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Opko Health Inc’s stock price was USD 1.20. Opko Health Inc’s stock price has changed by +29.03% over the past week, +21.77% over the past month and -13.67% over the last year.

No recent analyst target price found for Opko Health Inc
No recent average analyst rating found for Opko Health Inc

Company Overview Opko Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing...Read More

https://www.opko.com

4400 Biscayne Boulevard, Miami, FL, United States, 33137

3,930

December

USD

USA

Adjusted Closing Price for Opko Health Inc (OPK)

Loading...

Unadjusted Closing Price for Opko Health Inc (OPK)

Loading...

Share Trading Volume for Opko Health Inc Shares

Loading...

Compare Performance of Opko Health Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for OPK

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Opko Health Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc +0.36 (+0.07%) USD44.10B 52.65 36.72

ETFs Containing OPK

Symbol Name OPK's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Opko Health Inc (OPK) Stock

Based on ratings from 1 analysts Opko Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on OPK's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for OPK is USD 3.00 over the next 12 months. The maximum analyst target price is USD 3 while the minimum anlayst target price is USD 3.

OPK stock's Price/Earning ratio is 27.12. Our analysis grades OPK stock's Price / Earning ratio at F. This means that OPK stock's Price/Earning ratio is above 53% of the stocks in the Diagnostics & Research sector in the NSD exchange. Based on this OPK may be a overvalued for its sector.

The last closing price of OPK's stock was USD 1.20.

The most recent market capitalization for OPK is USD 0.67B.

Based on targets from 1 analysts, the average taret price for OPK is projected at USD 3.00 over the next 12 months. This means that OPK's stock price may go up by +150.00% over the next 12 months.

We can't find any ETFs which contains Opko Health Inc's stock.

As per our most recent records Opko Health Inc has 3,930 Employees.

Opko Health Inc's registered address is 4400 Biscayne Boulevard, Miami, FL, United States, 33137. You can get more information about it from Opko Health Inc's website at https://www.opko.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...